Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy
Author:
Affiliation:
1. Departments of Medicine and Public Health Sciences; Queen's University; Kingston Ontario Canada
2. Department of Medicine; Stanford University; Palo Alto CA
3. Department of Medicine; University of California San Francisco; San Francisco CA
Funder
Canadian Association for the Study of the Liver
Southeastern Ontario Academic Medical Association Clinician Scientist Program
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28923/fullpdf
Reference33 articles.
1. OPTN/SRTR 2012 Annual Data Report: liver;Kim;Am J Transplant,2014
2. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010
3. Chronic hepatitis C virus (HCV) disease burden and cost in the United States;Razavi;Hepatology,2013
4. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012
5. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study;Wu;Gastroenterology,2014
Cited by 203 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study;JHEP Reports;2024-09
2. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08
3. Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study;World Journal of Transplantation;2024-06-18
4. Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry;Transplant International;2024-05-07
5. Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis;Hepatology;2024-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3